H. Lee Moffitt Cancer Center and Research Institute, Inc.

Anthony M Magliocco

Yin Xiong

Soner Altiok

James J Mulé

Anders Erik Berglund

Jasreman Dhillon

Farah K Khalil

A method of distinguishing between lung squamous cell carcinoma and head and neck squamous cell carcinoma using a 22-gene biomarker signature is presented.

Method of distinguishing lung squamous cell carcinoma from head and neck squamous cell carcinoma

A method of distinguishing between urothelial carcinoma and squamous cell carcinoma of head and neck and lung primaries is presented. A 19-gene signature was developed which differentiates between metastatic urothelial carcinoma and squamous cell carcinoma in a metastatic site when the primary site is either known or unknown.

Method of distinguishing urothelial carcinoma from lung and head and neck squamous cell carcinoma

A method of identifying cancer patients who would be responsive to bladder sparing surgery plus chemoradiation therapy or cystectomy using expression of MRE11 in a nuclear to cytoplasmic ratio is presented.

Method for measuring MRE11 in tissues to predict cystectomy or bladder sparing surgery plus chemoradiation therapy

This invention relates to methods for treating subjects with bladder cancer, such as urothelial carcinoma, based on mRNA expression levels of chemokines.

Growing community of inventors

Orlando, FL, United States of America

Anthony M Magliocco